FULC Financials
Fulcrum Therapeutics Inc - Financial statements & key metrics
Stock Price
$8.29
Market Cap
$552.12M
EPS
$-1.18
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
-
Gross Profit
-
Operating Income
-
Net Income
$-9.72M
EPS (Diluted)
$-0.16
Balance Sheet Highlights
Total Assets
$260.72M
Total Liabilities
$17.68M
Shareholders Equity
-
Cash & Equivalents
$58.21M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-2.22M
CapEx
-
Free Cash Flow
-
Profitability Metrics
ROE
-0.3%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is FULC revenue?
View FULC's income statement for detailed revenue data.
Is FULC profitable?
FULC reported a loss of $9.72M in the most recent quarter.
What is FULC market cap?
FULC has a market capitalization of $552.12M, making it a small-cap stock.
Does FULC have debt?
View FULC's balance sheet for debt information.
What is FULC cash flow?
Cash flow data is available in the full financial statements.